|
REPORT COPYRIGHT VIOLATION IN MESSAGE
|
|
Subject
|
Pfizer and Moderna trial data shows increase in RSV for children. CDC turns a blind eye.
|
|
Poster Handle
|
Anonymous Coward |
|
Post Content
|
There has been an alarming spike in reported cases of Respiratory Syncytial Virus (RSV) in children. This influenza-like virus can be particularly dangerous in very young children and it typically rises in the winter months. What makes the current spike particularly alarming is that it is occurring off-season.
The clinical trial for Moderna’s pediatric Covid-19 vaccine, the children who received the vaccine experienced higher rates of RSV than those receiving the placebo. Similarly, in Pfizer’s pediatric Covid-19 vaccine trial, RSV was listed as one of the serious adverse events among children receiving this vaccine.
The issue is so serious that even the FDA’s vaccine committee, VRBPAC, which normally cheerleads even the most dangerous vaccine, noted the correlation and “stressed the importance of continued post-authorization safety surveillance, in particular for … certain respiratory infections (RSV and pneumonia) in the youngest age group, for which imbalances of uncertain clinical significance were observed in the clinical trial.”ICAN DEMANDS ANSWERS FROM THE CDC ABOUT SPIKE IN RSV RATES [ link to icandecide.org (secure)]
|
|
|
Please verify you're human:
|
|
|
Reason for copyright violation:
|
